Adjunctive vitamin D for treatment of active tuberculosis in India: A randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases

Volumn 15, Issue 5, 2015, Pages 528-534

  Daley, Peter ^a   Jagannathan, Vijayakumar ^b   John, K R ^c   Sarojini, Joy ^b   Latha, Asha ^b   Vieth, Reinhold ^d   Suzana, Shirly ^b   Jeyaseelan, Lakshmanan ^b   Christopher, Devasahayam J ^b   Smieja, Marek ^e   Mathai, Dilip ^f  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f Apollo Institute of Medical Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ALBUMIN; CALCIUM; CREATININE; PLACEBO; VITAMIN D; BACTERIUM ANTIBODY; IMMUNOLOGIC FACTOR; TUBERCULOSTATIC AGENT;

ADD ON THERAPY; ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; INDIAN; INTENTION TO TREAT ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM CULTURE; SPUTUM SMEAR; TUBERCULOSIS; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; ADOLESCENT; BIOSYNTHESIS; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTITUBERCULAR AGENTS; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VITAMIN D;

EID: 84928209680     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)70053-8     Document Type: Article

References (23)

1. International standards for tuberculosis care 2009, Tuberculosis Coalition for Technical Assistance (TBCTA), TBCTA, The Hague.
2. Williams C Cod liver oil in phthisis. Lond J Med 1849, 1:1-18.
3. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012, 5:819-829.
4. Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012, 79:1397-1405.
5. Song GG, Bae SC, Lee YH Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 2012, 31:1733-1739.
6. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012, 109:15449-15454.
7. Nursyam EW, Amin Z, Rumende CM The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006, 38:3-5.
8. Gwinup G, Randazzo G, Elias A The influence of vitamin D intake on serum calcium in tuberculosis. Acta Endocrinol 1981, 97:114-117.
9. Narang NK, Gupta RC, Jain MK Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India 1984, 32:185-188.
10. Morcos MM, Gabr AA, Samuel S, et al. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998, 137:157-164.
11. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377:242-250.
12. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009, 179:843-850.
13. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis 2013, 13:22.
14. Martineau AR, Nanzer AM, Satkunam KR, et al. Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis 2009, 13:119-125.
15. Annual status report. Revised National TB Control Program of India 2012, TB India 2012, Government of India, Delhi.
16. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007, 176:208-213.
17. Crissey SD, Ange KD, Jacobsen KL, et al. Serum concentrations of lipids, vitamin D metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos. J Nutr 2003, 133:160-166.
18. Epstein M, Schluger N, Davidow A, Bonk S, Rom W, Hanna B Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 1998, 113:379-386.
19. Karnofsky DA, Burchenal JH The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents 1949, 191-205. Columbia University Press, New York. C.M. MacLeod (Ed.).
20. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
21. Iseman MD Tuberculosis therapy: past, present and future. Eur Resp J Suppl 2002, 36:87s-94s.
22. Rustomjee R, Lienhardt C, Kanyok T, et al. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2008, 12:128-138.
23. Ralph AP, Waramori G, Pontororing GJ, et al. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One 2013, 8:e70032.